Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities
Xinan Wang, Giuseppe Lamberti, Alessandro Di Federico, Joao V. Alessi, Roberto Ferrara, M.L. Sholl, Mark M. Awad, Natalie I. Vokes, Biagio Ricciuti
Topics & Concepts
PembrolizumabMedicineImmunotherapyBlockadeBiomarkerOncologyCancerImmune checkpointInternal medicineCancer immunotherapyGeneticsBiologyReceptorCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics